NCT06380751

Brief Summary

The primary objective of the study is to measure efficacy of saruparib (AZD5305) plus camizestrant compared with physician's choice CDK4/6i plus ET in patients with BRCA1, BRCA2, or PALB2m, HR-positive, HER2-negative (defined as IHC 0, 1+, 2+/ ISH non-amplified) advanced breast cancer

Trial Health

88
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Strong global presence with extensive site network
Enrollment
500

participants targeted

Target at P50-P75 for phase_3

Timeline
53mo left

Started Aug 2024

Longer than P75 for phase_3

Geographic Reach
28 countries

294 active sites

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress30%
Aug 2024Oct 2030

First Submitted

Initial submission to the registry

March 25, 2024

Completed
1 month until next milestone

First Posted

Study publicly available on registry

April 24, 2024

Completed
3 months until next milestone

Study Start

First participant enrolled

August 1, 2024

Completed
4.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 30, 2029

Expected
1.6 years until next milestone

Study Completion

Last participant's last visit for all outcomes

October 18, 2030

Last Updated

May 15, 2026

Status Verified

May 1, 2026

Enrollment Period

4.7 years

First QC Date

March 25, 2024

Last Update Submit

May 14, 2026

Conditions

Outcome Measures

Primary Outcomes (1)

  • Progression-Free Survival

    PFS is defined as time from randomisation until progression per RECIST v1.1 as assessed by BICR, or death due to any cause.

    Up to approximately 59 months

Secondary Outcomes (11)

  • Overall Survival

    Up to approximately 88 months

  • Progression Free Survival 2

    Up to approximately 59 months

  • Time to chemotherapy

    Up to approximately 59 months

  • Objective Response Rate

    Up to approximately 59 months

  • Duration of Response

    Up to approximately 59 months

  • +6 more secondary outcomes

Study Arms (3)

Arm 1: saruparib (AZD5305) plus camizestrant

EXPERIMENTAL

participants will receive saruparib (AZD5305) orally and camizestrant orally

Drug: Saruparib (AZD5305)Drug: Camizestrant

Arm 2: Physician's choice CDK4/6i plus physician's choice ET

ACTIVE COMPARATOR

agents are indicated below and should follow local guidelines: * Physician's Choice CDK4/6i: * abemaciclib orally, or * ribociclib orally, or * palbociclib orally. * Physician's Choice ET: * fulvestrant intramuscularly, or * One of the following AIs: * letrozole orally, or * anastrozole orally, or * exemestane orally

Drug: AbemaciclibDrug: RibociclibDrug: PalbociclibDrug: FulvestrantDrug: LetrozoleDrug: AnastrozoleDrug: Exemestane

Arm 3: Physician's choice CDK4/6i plus camizestrant

EXPERIMENTAL

participants will receive camizestrant orally. Agents for CDK4/6i treatment are indicated above and should follow local guidelines

Drug: CamizestrantDrug: AbemaciclibDrug: RibociclibDrug: Palbociclib

Interventions

Saruparib (AZD5305) is a potent and selective inhibitor of PARP1, with minimal effect on PARP2.

Arm 1: saruparib (AZD5305) plus camizestrant

Camizestrant (AZD9833) is an orally bioavailable, next generation SERD with non-clinical and clinical activity in both ESR1 mutant and wild type settings .

Arm 1: saruparib (AZD5305) plus camizestrantArm 3: Physician's choice CDK4/6i plus camizestrant

CDK4/6 Inhibitor

Arm 2: Physician's choice CDK4/6i plus physician's choice ETArm 3: Physician's choice CDK4/6i plus camizestrant

CDK4/6 Inhibitor

Arm 2: Physician's choice CDK4/6i plus physician's choice ETArm 3: Physician's choice CDK4/6i plus camizestrant

CDK 4/6 Inhibitor

Arm 2: Physician's choice CDK4/6i plus physician's choice ETArm 3: Physician's choice CDK4/6i plus camizestrant

Endocrine Therapy

Arm 2: Physician's choice CDK4/6i plus physician's choice ET

Endorcine Therapy

Arm 2: Physician's choice CDK4/6i plus physician's choice ET

Endocrine Therapy

Arm 2: Physician's choice CDK4/6i plus physician's choice ET

Endocrine Therapy

Arm 2: Physician's choice CDK4/6i plus physician's choice ET

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Adult females, pre/peri-menopausal and/or post-menopausal, and adult males
  • Histologically or cytologically documented diagnosis of HR-positive, HER2-negative breast cancer
  • Advanced breast cancer with either locally advanced disease not amenable to curative treatment or metastatic disease
  • ECOG performance status of 0 or 1 with no deterioration over the previous 2 weeks
  • FFPE tumour tissue from each participant
  • Documented germline tumour loss of function mutation in BRCA1, BRCA2, or PALB2
  • Adequate organ and marrow function

You may not qualify if:

  • Participants with history of MDS/AML or with features suggestive of MDS/AML
  • Participants with any known predisposition to bleeding
  • Any history of persisting severe cytopenia
  • Any evidence of severe or uncontrolled systemic diseases or active uncontrolled infections
  • Refractory nausea and vomiting, chronic GI disease, inability to swallow the formulated product, or previous significant bowel resection
  • History of another primary malignancy
  • Persistent toxicities (CTCAE Grade ≥ 2) caused by previous anti-cancer therapy excluding alopecia
  • Spinal cord compression, brain metastases, carcinomatous meningitis, or leptomeningeal disease
  • Evidence of active and uncontrolled hepatitis B and/or hepatitis C
  • Evidence of active and uncontrolled HIV infection
  • Active tuberculosis infection
  • Cardiac criteria, including history of arrythmia and cardiovascular disease
  • Concurrent exogenous reproductive hormone therapy or non-topical hormonal therapy for non-cancer-related conditions
  • Major surgical procedure or significant traumatic injury within 4 weeks of the first dose of study intervention or an anticipated need for major surgery during the study
  • Palliative radiotherapy with a limited field of radiation within 2 weeks or with wide field of radiation or to more than 30% of the bone marrow within 4 weeks before the first dose of study treatment
  • +13 more criteria

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (298)

Research Site

Gilbert, Arizona, 85234, United States

RECRUITING

Research Site

Fountain Valley, California, 92708, United States

RECRUITING

Research Site

Glendale, California, 91206, United States

RECRUITING

Research Site

Los Angeles, California, 90089, United States

RECRUITING

Research Site

Newport Beach, California, 92663, United States

RECRUITING

Research Site

Aurora, Colorado, 80045, United States

RECRUITING

Research Site

Grand Junction, Colorado, 81501, United States

WITHDRAWN

Research Site

Hollywood, Florida, 33021, United States

RECRUITING

Research Site

Jacksonville, Florida, 32224, United States

RECRUITING

Research Site

Orlando, Florida, 32806, United States

WITHDRAWN

Research Site

Chicago, Illinois, 60611, United States

RECRUITING

Research Site

Evanston, Illinois, 60201, United States

RECRUITING

Research Site

Park Ridge, Illinois, 60068, United States

WITHDRAWN

Research Site

Urbana, Illinois, 61801, United States

RECRUITING

Research Site

Winfield, Illinois, 60190, United States

RECRUITING

Research Site

Indianapolis, Indiana, 46227, United States

WITHDRAWN

Research Site

Louisville, Kentucky, 40207, United States

WITHDRAWN

Research Site

Baltimore, Maryland, 21201, United States

NOT YET RECRUITING

Research Site

Silver Spring, Maryland, 20902, United States

RECRUITING

Research Site

Silver Spring, Maryland, 20904, United States

RECRUITING

Research Site

Boston, Massachusetts, 02215, United States

RECRUITING

Research Site

Dearborn, Michigan, 48126, United States

WITHDRAWN

Research Site

Detroit, Michigan, 48202, United States

RECRUITING

Research Site

Royal Oak, Michigan, 48073, United States

WITHDRAWN

Research Site

Royal Oak, Michigan, 48073, United States

RECRUITING

Research Site

Rochester, Minnesota, 55905, United States

RECRUITING

Research Site

Springfield, Missouri, 65804, United States

RECRUITING

Research Site

St Louis, Missouri, 63110, United States

NOT YET RECRUITING

Research Site

Camden, New Jersey, 08103, United States

RECRUITING

Research Site

New Brunswick, New Jersey, 08901, United States

WITHDRAWN

Research Site

Brooklyn, New York, 11220, United States

WITHDRAWN

Research Site

Mineola, New York, 11501, United States

RECRUITING

Research Site

New Hyde Park, New York, 11042, United States

WITHDRAWN

Research Site

New York, New York, 10016, United States

RECRUITING

Research Site

New York, New York, 10028, United States

WITHDRAWN

Research Site

New York, New York, 10065, United States

RECRUITING

Research Site

Shirley, New York, 11967, United States

WITHDRAWN

Research Site

Stony Brook, New York, 11790, United States

RECRUITING

Research Site

The Bronx, New York, 10469, United States

WITHDRAWN

Research Site

Westbury, New York, 11590, United States

WITHDRAWN

Research Site

Hershey, Pennsylvania, 17033, United States

RECRUITING

Research Site

Philadelphia, Pennsylvania, 19104, United States

RECRUITING

Research Site

Pittsburgh, Pennsylvania, 15215, United States

RECRUITING

Research Site

West Columbia, South Carolina, 29169, United States

WITHDRAWN

Research Site

Chattanooga, Tennessee, 37404, United States

RECRUITING

Research Site

Nashville, Tennessee, 37203, United States

RECRUITING

Research Site

Houston, Texas, 77030, United States

WITHDRAWN

Research Site

Houston, Texas, 77030, United States

RECRUITING

Research Site

Houston, Texas, 77054, United States

RECRUITING

Research Site

San Antonio, Texas, 78240, United States

RECRUITING

Research Site

Norfolk, Virginia, 23502, United States

RECRUITING

Research Site

Tacoma, Washington, 98405, United States

RECRUITING

Research Site

Morgantown, West Virginia, 26506, United States

RECRUITING

Research Site

Milwaukee, Wisconsin, 53215, United States

WITHDRAWN

Research Site

Ciudad Autónoma Buenos Aires, 1125, Argentina

RECRUITING

Research Site

Ciudad de Buenos Aires, 1015, Argentina

RECRUITING

Research Site

Ciudad de Buenos Aires, C1280AEB, Argentina

RECRUITING

Research Site

Córdoba, 5008, Argentina

RECRUITING

Research Site

Rosario, S2000KZE, Argentina

RECRUITING

Research Site

Salta, A4400EMI, Argentina

RECRUITING

Research Site

San Miguel de Tucumán, 4000, Argentina

WITHDRAWN

Research Site

Darlinghurst, 2010, Australia

RECRUITING

Research Site

Darlinghurst, 2139, Australia

RECRUITING

Research Site

Malvern, 3144, Australia

WITHDRAWN

Research Site

Melbourne, VIC 3000, Australia

RECRUITING

Research Site

Graz, 8036, Austria

RECRUITING

Research Site

Innsbruck, 6020, Austria

RECRUITING

Research Site

Linz, 4010, Austria

RECRUITING

Research Site

Vienna, 1090, Austria

RECRUITING

Research Site

Cachoeira de Itapemirim, 29308-055, Brazil

RECRUITING

Research Site

Curitiba, 80060-900, Brazil

RECRUITING

Research Site

Fortaleza, 60336-045, Brazil

RECRUITING

Research Site

Goiânia, 74000-000, Brazil

RECRUITING

Research Site

Jaú, 17210-120, Brazil

RECRUITING

Research Site

Porto Alegre, 91350-200, Brazil

RECRUITING

Research Site

Ribeirão Preto, 14049-901, Brazil

RECRUITING

Research Site

Salvador, 41253-190, Brazil

RECRUITING

Research Site

São Paulo, 01509-900, Brazil

RECRUITING

Research Site

São Paulo, 03102-002, Brazil

RECRUITING

Research Site

Plovdiv, 4002, Bulgaria

RECRUITING

Research Site

Sofia, 1527, Bulgaria

RECRUITING

Research Site

Stara Zagora, 6003, Bulgaria

RECRUITING

Research Site

Vratsa, 3000, Bulgaria

WITHDRAWN

Research Site

Toronto, Ontario, M5G 2M9, Canada

NOT YET RECRUITING

Research Site

Greenfield Park, Quebec, J4V 2G9, Canada

NOT YET RECRUITING

Research Site

Montreal, Quebec, H2X 0A9, Canada

NOT YET RECRUITING

Research Site

Montreal, Quebec, H3T 1E2, Canada

NOT YET RECRUITING

Research Site

Montreal, Quebec, H4A 3J1, Canada

NOT YET RECRUITING

Research Site

Saskatoon, Saskatchewan, S7N 4H4, Canada

NOT YET RECRUITING

Research Site

Toronto, M4N 3M5, Canada

NOT YET RECRUITING

Research Site

Providencia, 7500994, Chile

RECRUITING

Research Site

Recoleta, 8420391, Chile

RECRUITING

Research Site

Santiago, 8330034, Chile

RECRUITING

Research Site

Talca, 3461341, Chile

RECRUITING

Research Site

Viña del Mar, 2520000, Chile

RECRUITING

Research Site

Beijing, 100044, China

RECRUITING

Research Site

Bengbu, 233004, China

RECRUITING

Research Site

Changchun, 130012, China

RECRUITING

Research Site

Changchun, 130021, China

RECRUITING

Research Site

Changsha, 410008, China

RECRUITING

Research Site

Changsha, 410013, China

RECRUITING

Research Site

Chengdu, 610000, China

RECRUITING

Research Site

Chengdu, 610072, China

RECRUITING

Research Site

Chongqing, 400042, China

RECRUITING

Research Site

Foshan, 528000, China

RECRUITING

Research Site

Fuzhou, 350014, China

RECRUITING

Research Site

Guangzhou, 510060, China

RECRUITING

Research Site

Guangzhou, 510062, China

RECRUITING

Research Site

Guangzhou, 510289, China

RECRUITING

Research Site

Hangzhou, 310016, China

RECRUITING

Research Site

Hangzhou, 310022, China

RECRUITING

Research Site

Harbin, 150081, China

RECRUITING

Research Site

Hefei, 230031, China

RECRUITING

Research Site

Hohhot, 010017, China

WITHDRAWN

Research Site

Jining, 272029, China

RECRUITING

Research Site

Kunming, 650118, China

NOT YET RECRUITING

Research Site

Liuzhou, 545006, China

RECRUITING

Research Site

Luoyang, 471000, China

RECRUITING

Research Site

Nanchang, 330006, China

WITHDRAWN

Research Site

Nanchang, 330009, China

RECRUITING

Research Site

Nanjing, 210029, China

RECRUITING

Research Site

Shandong, 250117, China

RECRUITING

Research Site

Shanghai, 200025, China

RECRUITING

Research Site

Shanghai, 200120, China

RECRUITING

Research Site

Shenyang, 110016, China

RECRUITING

Research Site

Shijiazhuang, 050000, China

RECRUITING

Research Site

Tianjin, 300000, China

RECRUITING

Research Site

Weifang, 261000, China

RECRUITING

Research Site

Wuhan, 430030, China

RECRUITING

Research Site

Wuhan, 430040, China

RECRUITING

Research Site

Wuhan, 430079, China

RECRUITING

Research Site

Xi'an, 710006, China

RECRUITING

Research Site

Xi'an, 710061, China

RECRUITING

Research Site

Xiamen, 361003, China

RECRUITING

Research Site

Xiangyang, 441000, China

RECRUITING

Research Site

Xinxiang, 453100, China

RECRUITING

Research Site

Zhengzhou, 450008, China

RECRUITING

Research Site

Brno, 656 53, Czechia

RECRUITING

Research Site

Hořovice, 26831, Czechia

RECRUITING

Research Site

Hradec Králové, 500 05, Czechia

RECRUITING

Research Site

Olomouc, 77900, Czechia

RECRUITING

Research Site

Prague, 120 00, Czechia

RECRUITING

Research Site

Prague, 180 00, Czechia

NOT YET RECRUITING

Research Site

Angers, 49100, France

RECRUITING

Research Site

Besançon, 25030, France

SUSPENDED

Research Site

Lille, 59000, France

RECRUITING

Research Site

Lyon, 69373, France

RECRUITING

Research Site

Marseille, 13273, France

RECRUITING

Research Site

Paris, 75005, France

RECRUITING

Research Site

Rouen, 76021, France

RECRUITING

Research Site

Saint-Herblain, 44805, France

RECRUITING

Research Site

Toulouse, 31059, France

RECRUITING

Research Site

Villejuif, 94805, France

RECRUITING

Research Site

Aachen, 52074, Germany

RECRUITING

Research Site

Augsburg, 86150, Germany

WITHDRAWN

Research Site

Berlin, 13125, Germany

RECRUITING

Research Site

Cologne, 50937, Germany

WITHDRAWN

Research Site

Dessau, 06847, Germany

RECRUITING

Research Site

Düsseldorf, 40225, Germany

RECRUITING

Research Site

Erlangen, 91054, Germany

RECRUITING

Research Site

Göttingen, DE-37099, Germany

RECRUITING

Research Site

Hamburg, 20357, Germany

RECRUITING

Research Site

Hanover, 30625, Germany

RECRUITING

Research Site

Heidelberg, 69120, Germany

RECRUITING

Research Site

Kiel, 24105, Germany

RECRUITING

Research Site

Leipzig, 04103, Germany

RECRUITING

Research Site

Ludwigsburg, 71640, Germany

RECRUITING

Research Site

München, 81675, Germany

RECRUITING

Research Site

Münster, 48149, Germany

RECRUITING

Research Site

Hong Kong, 150001, Hong Kong

NOT YET RECRUITING

Research Site

Hong Kong, 999077, Hong Kong

NOT YET RECRUITING

Research Site

Budapest, 1082, Hungary

RECRUITING

Research Site

Budapest, 1122, Hungary

RECRUITING

Research Site

Budapest, 1145, Hungary

RECRUITING

Research Site

Debrecen, 4032, Hungary

NOT YET RECRUITING

Research Site

Miskolc, 3526, Hungary

RECRUITING

Research Site

Zalaegerszeg, 8900, Hungary

RECRUITING

Research Site

Delhi, 110029, India

RECRUITING

Research Site

Kolkata, 700160, India

WITHDRAWN

Research Site

Lucknow, 226003, India

WITHDRAWN

Research Site

Mumbai, 400012, India

RECRUITING

Research Site

Mumbai, 400052, India

RECRUITING

Research Site

Mysuru, 570017, India

RECRUITING

Research Site

Nagpur, 440001, India

RECRUITING

Research Site

Nashik, 422002, India

RECRUITING

Research Site

New Delhi, 110085, India

RECRUITING

Research Site

Surat, 396007, India

RECRUITING

Research Site

Thiruvananthapuram, 695011, India

RECRUITING

Research Site

Jerusalem, 9103102, Israel

RECRUITING

Research Site

Jerusalem, 9112001, Israel

RECRUITING

Research Site

Petah Tikva, 49100, Israel

RECRUITING

Research Site

Ramat Gan, 52621, Israel

RECRUITING

Research Site

Tel Aviv, 64239, Israel

RECRUITING

Research Site

Bergamo, 24127, Italy

RECRUITING

Research Site

Bologna, 40138, Italy

RECRUITING

Research Site

Milan, 20132, Italy

RECRUITING

Research Site

Milan, 20141, Italy

RECRUITING

Research Site

Modena, 41124, Italy

WITHDRAWN

Research Site

Naples, 80131, Italy

RECRUITING

Research Site

Padova, 35128, Italy

RECRUITING

Research Site

Reggio Emilia, 422122, Italy

RECRUITING

Research Site

Rome, 00168, Italy

RECRUITING

Research Site

Rozzano, 20089, Italy

RECRUITING

Research Site

Chiba, 260-8717, Japan

RECRUITING

Research Site

Hidaka-shi, 350-1298, Japan

RECRUITING

Research Site

Hirakata-shi, 573-1191, Japan

RECRUITING

Research Site

Isehara-shi, 259-1193, Japan

RECRUITING

Research Site

Kagoshima, 892-0833, Japan

RECRUITING

Research Site

Kashiwa, 227-8577, Japan

RECRUITING

Research Site

Kōtoku, 135-8550, Japan

RECRUITING

Research Site

Kumamoto, 860-8556, Japan

RECRUITING

Research Site

Kyoto, 606-8507, Japan

RECRUITING

Research Site

Matsuyama, 791-0280, Japan

RECRUITING

Research Site

Nagoya, 464-8681, Japan

RECRUITING

Research Site

Nagoya, 466-8560, Japan

RECRUITING

Research Site

Nagoya, 467-8602, Japan

RECRUITING

Research Site

Osaka, 541-8567, Japan

RECRUITING

Research Site

Ota-shi, 373-8550, Japan

RECRUITING

Research Site

Sapporo, 003-0804, Japan

RECRUITING

Research Site

Sendai, 980-8574, Japan

RECRUITING

Research Site

Shinagawa-ku, 142-8666, Japan

RECRUITING

Research Site

Suita-shi, 565-0871, Japan

RECRUITING

Research Site

Sunto-gun, 411-8777, Japan

RECRUITING

Research Site

Takasaki-shi, 370-0829, Japan

RECRUITING

Research Site

Tsu, 514-8507, Japan

RECRUITING

Research Site

Yokohama, 241-8515, Japan

RECRUITING

Research Site

Bandar Puncak Alam, 42300, Malaysia

NOT YET RECRUITING

Research Site

Johor Bahru, 81100, Malaysia

RECRUITING

Research Site

Kuala Lumpur, 59100, Malaysia

RECRUITING

Research Site

Kuala Selangor, 62250, Malaysia

RECRUITING

Research Site

Malacca, 75000, Malaysia

RECRUITING

Research Site

Bellavista, CALLAO 2, Peru

NOT YET RECRUITING

Research Site

Jesus Maria, Lima, LIMA 11, Peru

NOT YET RECRUITING

Research Site

Lima, 15036, Peru

NOT YET RECRUITING

Research Site

Lima, LIMA 29, Peru

NOT YET RECRUITING

Research Site

Biała Podlaska, 21-500, Poland

WITHDRAWN

Research Site

Koszalin, 75-581, Poland

RECRUITING

Research Site

Lodz, 93-338, Poland

RECRUITING

Research Site

Lublin, 20-090, Poland

RECRUITING

Research Site

Poznan, 60-569, Poland

RECRUITING

Research Site

Poznan, 61-485, Poland

WITHDRAWN

Research Site

Radom, 26-600, Poland

NOT YET RECRUITING

Research Site

Warsaw, 02-781, Poland

RECRUITING

Research Site

Coimbra, 3000-075, Portugal

RECRUITING

Research Site

Lisbon, 1099-023, Portugal

RECRUITING

Research Site

Lisbon, 1998-018, Portugal

RECRUITING

Research Site

Matosinhos Municipality, 4454-509, Portugal

RECRUITING

Research Site

Porto, 4050-115, Portugal

RECRUITING

Research Site

Vila Real, 5000-508, Portugal

RECRUITING

Research Site

San Juan, 00918, Puerto Rico

RECRUITING

Research Site

Daegu, 41404, South Korea

RECRUITING

Research Site

Seongnam-si, 13620, South Korea

RECRUITING

Research Site

Seoul, 02841, South Korea

RECRUITING

Research Site

Seoul, 03080, South Korea

RECRUITING

Research Site

Seoul, 06273, South Korea

RECRUITING

Research Site

Seoul, 06351, South Korea

RECRUITING

Research Site

Seoul, 3722, South Korea

RECRUITING

Research Site

Seoul, 5505, South Korea

RECRUITING

Research Site

A Coruña, 15009, Spain

NOT YET RECRUITING

Research Site

Barcelona, 08035, Spain

RECRUITING

Research Site

Cáceres, 10003, Spain

WITHDRAWN

Research Site

Granada, 18007, Spain

RECRUITING

Research Site

L'Hospitalet de Llobregat, 08908, Spain

RECRUITING

Research Site

Madrid, 28040, Spain

RECRUITING

Research Site

Madrid, 28041, Spain

RECRUITING

Research Site

Málaga, 29010, Spain

RECRUITING

Research Site

Pamplona, 31008, Spain

WITHDRAWN

Research Site

Seville, 41013, Spain

RECRUITING

Research Site

Valencia, 46006, Spain

RECRUITING

Research Site

Zaragoza, 50009, Spain

NOT YET RECRUITING

Research Site

New Taipei City, 23561, Taiwan

RECRUITING

Research Site

Taichung, Taiwan

RECRUITING

Research Site

Tainan, 704, Taiwan

RECRUITING

Research Site

Taipei, 100, Taiwan

RECRUITING

Research Site

Taipei, 10449, Taiwan

RECRUITING

Research Site

Taipei, 112, Taiwan

RECRUITING

Research Site

Taoyuan, 00333, Taiwan

RECRUITING

Research Site

Bangkok, 10210, Thailand

RECRUITING

Research Site

Bangkok, 10330, Thailand

RECRUITING

Research Site

Dusit, 10300, Thailand

TERMINATED

Research Site

Hat Yai, 90110, Thailand

RECRUITING

Research Site

Muang, 22000, Thailand

NOT YET RECRUITING

Research Site

Ratchathewi, 10400, Thailand

RECRUITING

Research Site

Ratchathewi, 10400, Thailand

NOT YET RECRUITING

Research Site

Adapazarı, 54290, Turkey (Türkiye)

RECRUITING

Research Site

Altındağ-Ankara, 06230, Turkey (Türkiye)

RECRUITING

Research Site

Ankara, 06530, Turkey (Türkiye)

NOT YET RECRUITING

Research Site

Çankaya, 06680, Turkey (Türkiye)

WITHDRAWN

Research Site

Istanbul, 34214, Turkey (Türkiye)

RECRUITING

Research Site

Kayseri, 38039, Turkey (Türkiye)

RECRUITING

Research Site

Cambridge, CB2 2QQ, United Kingdom

RECRUITING

Research Site

Guildford, GU2 7XX, United Kingdom

RECRUITING

Research Site

London, SE1 9RT, United Kingdom

RECRUITING

Research Site

Manchester, M20 4BX, United Kingdom

RECRUITING

Research Site

Oxford, OX3 7LE, United Kingdom

WITHDRAWN

Research Site

Swansea, SA2 8QA, United Kingdom

WITHDRAWN

Research Site

Taunton, TA1 5DA, United Kingdom

RECRUITING

Research Site

Truro, TR1 3LJ, United Kingdom

RECRUITING

MeSH Terms

Interventions

AZD5305AZD9833abemaciclibribociclibpalbociclibFulvestrantLetrozoleAnastrozoleexemestane

Intervention Hierarchy (Ancestors)

EstradiolEstrenesEstranesSteroidsFused-Ring CompoundsPolycyclic CompoundsEstradiol CongenersGonadal Steroid HormonesGonadal HormonesHormonesHormones, Hormone Substitutes, and Hormone AntagonistsNitrilesOrganic ChemicalsTriazolesAzolesHeterocyclic Compounds, 1-RingHeterocyclic Compounds

Central Study Contacts

AstraZeneca Clinical Study Information Center

CONTACT

Study Design

Study Type
interventional
Phase
phase 3
Allocation
RANDOMIZED
Masking
NONE
Masking Details
Open label
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 25, 2024

First Posted

April 24, 2024

Study Start

August 1, 2024

Primary Completion (Estimated)

March 30, 2029

Study Completion (Estimated)

October 18, 2030

Last Updated

May 15, 2026

Record last verified: 2026-05

Data Sharing

IPD Sharing
Will share

Qualified researchers can request access to anonymized individual patient-level data from AstraZeneca group of companies sponsored clinical trials via the request portal Vivli.org. All requests will be evaluated as per the AZ disclosure commitment: https://astrazenecagrouptrials.pharmacm.com/ST/Submission/Disclosure

Shared Documents
STUDY PROTOCOL, SAP
Time Frame
AstraZeneca will meet or exceed data availability as per the commitments made to the EFPIA/PhRMA Data-Sharing Principles. For details of our timelines, please refer to our disclosure commitment at https://astrazenecagrouptrials.pharmacm.com/ST/Submission/Disclosure
Access Criteria
When a request has been approved AstraZeneca will provide access to the anonymized individual patient-level data via secure research environment Vivli.org. A Signed Data Usage Agreement (non-negotiable contract for data accessors) must be in place before accessing requested information
More information

Locations